Skip to main content
SNDX logo
SNDX
(NASDAQ)
Syndax Pharmaceuticals, Inc.
$25.15-- (--)
Loading... - Market loading

Syndax Pharmaceuticals, Inc. (SNDX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Syndax Pharmaceuticals, Inc. stock.

Analyst Consensus Rating

Investment consensus from 6 professional research analysts

Consensus Rating

Strong Buy
Based on 6 unique analysts
Medium Confidence:1 Buy/Sell

Average Price Target

$136.50
442.74% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest SNDX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Corinne Johnson
Goldman Sachs
Strong BuyMaintains
$28.00 $34.00
Salim Syed
Mizuho
BuyMaintains
$45.00 $43.00
Faisal Khurshid
Jefferies
Strong BuyInitiates
$48.00 $40.00
Anupam Rama
JP Morgan
BuyMaintains
$33.00 $45.00
Yigal Nochomovitz
Citi
Strong BuyMaintains
$51.00 $57.00
Mara Goldstein
Mizuho
BuyMaintains
$410.00 $600.00

Frequently Asked Questions

What is the analyst consensus rating for SNDX?

The analyst consensus rating for SNDX is "Strong Buy" based on 6 analyst recommendations.

What is the average price target for SNDX?

The average 12-month price target for SNDX is $136.50, representing an upside of 442.7% from the current price of $25.15.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.